Professor Elio Riboli is Chair in Cancer Epidemiology and Prevention and was formerly the Director of the School of Public Health at Imperial College London, rated one of the top two epidemiology and public health submissions to the UK’s Research Assessment Exercise (RAE) in 2009. He holds an M.D. degree (1977, State University of Milan), a Master of Public Health (1980, Milan) and a Master of Science in Epidemiology (1982, Harvard University). Professor Riboli is a Registered Physician (General Medical Council, UK, 2005) and an Honorary Fellow of the Royal College of Physicians (2008).
From 1983 to 2005 Professor Riboli was based at Lyon’s the International Agency for Research on Cancer (IARC), where he developed new research projects in the areas of nutrition, nutritional status and cancer. In 1989 he initiated the European Prospective Investigation into Cancer and Nutrition (EPIC), which sampled data from 500,000 subjects across 26 centres in ten countries. He was Head of the Nutrition and Hormones Group of IARC from 2004 to 2005.
Professor Riboli has co-authored over 310 peer-reviewed publications and over 100 book chapters and books and serves on editorial boards of major journals on nutrition, cancer and epidemiology.
In 2005 he joined Imperial College London as Professor of Cancer Epidemiology; in 2006 he was appointed Divisional Head of Epidemiology, Public Health and Primary Care, which later become the School of Public Health. Professor Riboli stepped down as Head of the School at the end of 2017.
Riboli E, General and abdominal adiposity and the risk of parkinson's disease.A prospective chort study, Parkinsonism and Related Disorders, ISSN:1353-8020
et al., 2019, Meeting Report from the joint IARC-NCI international cancer seminar series: a focus on colorectal cancer., Ann Oncol
et al., 2019, Reproductive Factors, Exogenous Hormone Use, and Risk of B-Cell Non-Hodgkin Lymphoma in a Cohort of Women From the European Prospective Investigation Into Cancer and Nutrition., Am J Epidemiol, Vol:188, Pages:274-281
et al., 2019, Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk, Cancer Research, Vol:79, ISSN:0008-5472, Pages:505-517
et al., 2019, Methodological issues in a prospective study on plasma concentrations of persistent organic pollutants and pancreatic cancer risk within the EPIC cohort., Environ Res, Vol:169, Pages:417-433